Key facts
- This page summarizes Ronald E. Blaylock's Form 4 filing for PFIZER INC (PFE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 27 Apr 2026, 18:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each unit represents one phantom share of common stock.
Footnote F2
Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
Footnote F3
These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.